Literature DB >> 16448737

Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO).

Scott E Loveless1, Carol Finlay, Nancy E Everds, Steven R Frame, Peter J Gillies, John C O'Connor, Charles R Powley, Gerald L Kennedy.   

Abstract

The purpose of this study was to compare the toxicity of linear/branched ammonium perfluorooctanoate (APFO) with that of linear and branched APFO. Linear/branched APFO (approximately 80% linear and 20% branched isomers) was formerly used in the production of commercial products. The extensive toxicologic database for APFO has been developed essentially using this mixture of isomers. The trend now is to use APFO containing only the linear isomer. The current study was performed to determine if the toxicological database developed for the linear/branched isomer is applicable to the linear isomer. To determine the contribution of branched APFO to the toxicity of linear/branched APFO, a form of APFO that was 100% branched was synthesized. Rats and mice were given doses by oral gavage ranging from 0.3 to 30 mg/kg of either the linear/branched, linear, or branched APFO for 14 days. Clinical signs, body weights, food consumption, selected hematology and serum lipid parameters, liver and kidney weights, hepatic peroxisomal beta-oxidation, and serum PFOA concentrations were evaluated. Mean body weights were about 20% lower in rats and mice dosed with 30 mg/kg of linear/branched or linear APFO compared to controls, and 3-5% lower in animals dosed with 30 mg/kg of branched APFO. In rats, all three forms reduced lipids. In mice, all three forms reduced total and HDL cholesterol similarly but triglycerides were increased at lower doses. Increased peroxisomal beta-oxidation activity and serum PFOA concentrations were seen in both species but these effects were least pronounced in rats dosed with the branched material. In rats, serum PFOA levels were 20-51 ppm at Lowest Observed Effect Levels (LOEL) of 0.3-1 mg/kg, based primarily upon lipid parameters. In mice, serum PFOA levels were 10-14 ppm at the LOEL of 0.3 mg/kg, based primarily upon relative liver weight. In both rats and mice, the overall responses to the linear/branched and the linear forms of PFOA were similar, but the branched form appears to be less potent. Based on these results, and for the endpoints evaluated in this study, the toxicological database developed primarily from testing linear/branched APFO is applicable to linear APFO.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448737     DOI: 10.1016/j.tox.2006.01.003

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  24 in total

1.  Perfluoroalkyl substances with isomer analysis in umbilical cord serum in China.

Authors:  Ya-Zhi Zhang; Xiao-Wen Zeng; Zhengmin Min Qian; Michael G Vaughn; Sarah Dee Geiger; Li-Wen Hu; Long Lu; Chuanxi Fu; Guang-Hui Dong
Journal:  Environ Sci Pollut Res Int       Date:  2017-04-09       Impact factor: 4.223

Review 2.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

3.  Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha.

Authors:  Toshiki Nakamura; Yuki Ito; Yukie Yanagiba; Doni Hikmat Ramdhan; Yasuhide Kono; Hisao Naito; Yumi Hayashi; Yufei Li; Toshifumi Aoyama; Frank J Gonzalez; Tamie Nakajima
Journal:  Toxicology       Date:  2009-09-12       Impact factor: 4.221

4.  Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis.

Authors:  John F Wambaugh; Hugh A Barton; R Woodrow Setzer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-01-08       Impact factor: 2.745

5.  Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2020-02-20       Impact factor: 9.621

6.  Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.

Authors:  Jessica L Reiner; Shoji F Nakayama; Amy D Delinsky; Jason P Stanko; Suzanne E Fenton; Andrew B Lindstrom; Mark J Strynar
Journal:  Reprod Toxicol       Date:  2008-11-06       Impact factor: 3.143

Review 7.  Per- and polyfluoroalkyl substances in human breast milk and current analytical methods.

Authors:  Linda R Macheka-Tendenguwo; Joshua O Olowoyo; Liziwe L Mugivhisa; Ovokeroye A Abafe
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-01       Impact factor: 4.223

8.  The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.

Authors:  Miranda J Spratlen; Frederica P Perera; Sally Ann Lederman; Morgan Robinson; Kurunthachalam Kannan; Julie Herbstman; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

9.  Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth.

Authors:  Noriaki Washino; Yasuaki Saijo; Seiko Sasaki; Shizue Kato; Susumu Ban; Kanae Konishi; Rie Ito; Ayako Nakata; Yusuke Iwasaki; Koichi Saito; Hiroyuki Nakazawa; Reiko Kishi
Journal:  Environ Health Perspect       Date:  2008-11-04       Impact factor: 9.031

Review 10.  Toxicological function of adipose tissue: focus on persistent organic pollutants.

Authors:  Michele La Merrill; Claude Emond; Min Ji Kim; Jean-Philippe Antignac; Bruno Le Bizec; Karine Clément; Linda S Birnbaum; Robert Barouki
Journal:  Environ Health Perspect       Date:  2012-12-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.